Rettinger, E., Glatthaar, A., Abhari, B. A., Oelsner, S., Pfirrmann, V., Huenecke, S., . . . Bader, P. (2014). SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy. Frontiers Media S.A.
Citação norma ChicagoRettinger, Eva, et al. SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but Also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy. Frontiers Media S.A, 2014.
Citação norma MLARettinger, Eva, et al. SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but Also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy. Frontiers Media S.A, 2014.